Abu Dhabi, United Arab Emirates
+919405476170
+919405476170

Nitnib 50mg (Sunitinib) Wholesale UAE | Pharma Export India | Ernest Oncology

Nitnib 50mg Capsules (Sunitinib): Global Procurement & Clinical Overview



In the advanced management of specialized cancers, Nitnib 50mg Capsules (containing Sunitinib) represent a cornerstone of targeted therapy. As a premier pharmaceutical exporter from India, Ernest Oncology (part of the Group of Ernest Pharmaceutical Pvt. Ltd.) provides an end-to-end supply chain for this vital medication to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa.


This guide explores the clinical profile of Nitnib 50 mg and the strategic advantages of partnering with a verified Indian bulk supplier.




What is Nitnib 50 mg? 


Nitnib 50 mg is an oral multi-kinase inhibitor. Its active pharmaceutical ingredient, Sunitinib, works by blocking the signals that tell cancer cells to grow and divide. Unlike traditional chemotherapy, Nitnib is a targeted therapy designed to identify and attack specific cancer cells while minimizing damage to normal, healthy cells.


Primary Therapeutic Indications


Nitnib 50 mg is globally recognized and prescribed for:


  • Advanced Renal Cell Carcinoma (RCC): Used as a first-line treatment for advanced or metastatic kidney cancer.

  • Gastrointestinal Stromal Tumor (GIST): For patients whose disease has progressed or who are intolerant to Imatinib.

  • Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors located in the pancreas.



Clinical Mechanism and Efficacy:


Nitnib 50 mg functions through a dual-action process that inhibits tumor growth:

  1. Anti-Angiogenesis: It blocks the Vascular Endothelial Growth Factor (VEGF) receptors, effectively cutting off the blood supply that tumors need to survive and expand.

  2. Anti-Proliferation: It inhibits Platelet-Derived Growth Factor (PDGF) receptors, which stops the signals that trigger cancer cell multiplication.

Clinical data from the USA and UK show that Sunitinib 50 mg significantly improves progression-free survival (PFS) in patients with metastatic renal cell carcinoma.


Why Choose Ernest Oncology as Your Indian Exporter?

  • Reliable Bulk Supply: We manage high-volume orders for global institutional buyers.

  • Authenticity Guaranteed: Every pack of Nitnib 50mg is sourced through verified channels with full batch traceability.

  • Optimized Logistics: Expertise in international shipping ensures your medicine arrives safely and on time.

  • Competitive Pricing: Direct export from India allows for significant cost savings for international distributors.


Administration and Safety Information:


  • Dosage: The standard dose for RCC and GIST is often 50 mg once daily for 4 weeks, followed by a 2-week break. Always follow the oncologist's specific prescription.

  • Storage: Store at room temperature (20°C to 25°C) in a dry place.

  • Monitoring: Regular blood pressure checks and thyroid function tests are recommended during treatment.


📞 Contact Ernest Oncology—Pharmaceutical Exporter from India


[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD]


🌐 Websites:

📧 Email: exports@ernestpharmaceuticals.com 


📦 Business Type: Exporter | Bulk Supplier | Distributor 


📲 WhatsApp: +91 93599 02383 


🔗 WhatsApp Chat: https://wa.me/919359902383

 2026-03-21T06:12:35

Keywords